Multiple Endocrine Neoplasia Type 2b
What's New
Last Posted: Feb 06, 2019
- Natural history, treatment, and long-term follow up of patients with multiple endocrine neoplasia type 2B: an international, multicentre, retrospective study.
Castinetti Frederic et al. The lancet. Diabetes & endocrinology 2019 Jan - Long-Term Survivorship in Multiple Endocrine Neoplasia Type 2B Diagnosed Before and in the New Millennium.
Raue Friedhelm, et al. The Journal of clinical endocrinology and metabolism 2017 10 - M918V RET mutation causes familial medullary thyroid carcinoma: study of 8 affected kindreds.
Martins-Costa M Cecília, et al. Endocrine-related cancer 2016 12 (12) 909-920 - Screening of RET gene mutations in Chinese patients with medullary thyroid carcinoma and their relatives.
Wang Junyi, et al. Familial cancer 2015 8 - Thyroid Cancer—Patient Version
- Multiple endocrine neoplasia type 2B
From NCATS Genetic and Rare Diseases Information Center - Rapid diagnosis of MEN2B using unlabeled probe melting analysis and the LightCycler 480 instrument.
Margraf Rebecca L, et al. The Journal of molecular diagnostics : JMD 2008 3 (2) 123-8 - Germline RET mutations in exons 10 and 11: an Iranian survey of 57 medullary thyroid carcinoma cases.
Hedayati M, et al. The Medical journal of Malaysia 2006 12 (5) 564-9
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 29, 2024
- Content source: